
Porscha Johnson/LinkedIn
May 29, 2025, 16:26
Porscha Johnson: Two More Days Before Our Live Interactive Molecular Tumor Board at ASCO 2025
Porscha Johnson, Senior Oncology Medical Science Liaison at Johnson and Johnson Innovative Medicine, shared a post on LinkedIn:
“Two More days before our Live Interactive Molecular Tumor Board (MTB) at ASCO!!
Join our in-person breakfast session during ASCO to explore real-world applications of genomic profiling in cancer care!
Friday, May 30th | 8:30-11am CT
- Impact of comprehensive genomic profiling on therapeutic strategy
- Evolving classification of HER2-low and HER2-ultra-low disease
- Clinical application of ctDNA monitoring
- Emerging role of personalized cancer vaccines”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 14:15
May 29, 2025, 13:35
May 29, 2025, 13:11